Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ARCTIUM LAPPA WHOLE

73070DU1LA

Status:

Possibly Marketed Outside US

Source:

M028

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0740e366-17ab-d3fa-e063-6294a90ae3e9

First approved in 2018

Source:

21 CFR 348

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7dd3df8d-dff1-473b-9151-93d6f606bb25

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

ARCTIUM LAPPA WHOLE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1